Grace M. Callagy

Costello Road
Gaillimh, C, Ireland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Management of high-risk (B3) breast lesions in symptomatic practice: evidence review and practical recommendations for multidisciplinary care.

Management of high-risk (B3) breast lesions in symptomatic practice: evidence review and practical recommendations for multidisciplinary care.

Journal: Virchows Archiv : an international journal of pathology

Published: June 19, 2026

Breast core needle biopsy diagnosis and personalized treatment: navigating pitfalls and challenging lesions.

Breast core needle biopsy diagnosis and personalized treatment: navigating pitfalls and challenging lesions.

Journal: Histopathology

Published: June 03, 2026

Margin Adequacy in Phyllodes Tumours Revisited: Reappraisal of the Evidence Base and Knowledge Gaps.

Margin Adequacy in Phyllodes Tumours Revisited: Reappraisal of the Evidence Base and Knowledge Gaps.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: February 20, 2026

International Expert Consensus Recommendations for HER2 Reporting in Breast Cancer: Focus on HER2-Low and Ultralow Categories.

International Expert Consensus Recommendations for HER2 Reporting in Breast Cancer: Focus on HER2-Low and Ultralow Categories.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: July 07, 2025

Malignant phyllodes tumours of the breast: the case for revising WHO's 'full house' diagnostic criteria.

Malignant phyllodes tumours of the breast: the case for revising WHO's 'full house' diagnostic criteria.

Journal: Histopathology

Published: April 14, 2025

Classification of Fibroepithelial Lesions of the Breast in Core Needle Biopsy With Implications for Further Management.

Classification of Fibroepithelial Lesions of the Breast in Core Needle Biopsy With Implications for Further Management.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: December 15, 2024

Digital image analysis and machine learning-assisted prediction of neoadjuvant chemotherapy response in triple-negative breast cancer.

Digital image analysis and machine learning-assisted prediction of neoadjuvant chemotherapy response in triple-negative breast cancer.

Journal: Research square

Published: August 30, 2023

Digital image analysis and machine learning-assisted prediction of neoadjuvant chemotherapy response in triple-negative breast cancer.

Digital image analysis and machine learning-assisted prediction of neoadjuvant chemotherapy response in triple-negative breast cancer.

Journal: Breast cancer research : BCR

Published: August 07, 2023

Concordance of HER2-low scoring in breast carcinoma among expert pathologists in the United Kingdom and the republic of Ireland -on behalf of the UK national coordinating committee for breast pathology.

Concordance of HER2-low scoring in breast carcinoma among expert pathologists in the United Kingdom and the republic of Ireland -on behalf of the UK national coordinating committee for breast pathology.

Journal: Breast (Edinburgh, Scotland)

Published: April 26, 2023

ONEST (Observers Needed to Evaluate Subjective Tests) Analysis of Stromal Tumour-Infiltrating Lymphocytes (sTILs) in Breast Cancer and Its Limitations.

ONEST (Observers Needed to Evaluate Subjective Tests) Analysis of Stromal Tumour-Infiltrating Lymphocytes (sTILs) in Breast Cancer and Its Limitations.

Journal: Cancers

Published: January 20, 2023

Inter- and Intra-Observer Agreement of PD-L1 SP142 Scoring in Breast Carcinoma-A Large Multi-Institutional International Study.

Inter- and Intra-Observer Agreement of PD-L1 SP142 Scoring in Breast Carcinoma-A Large Multi-Institutional International Study.

Journal: Cancers

Published: November 01, 2022

UK recommendations for HER2 assessment in breast cancer: an update.

UK recommendations for HER2 assessment in breast cancer: an update.

Journal: Journal of clinical pathology

Published: October 13, 2022

Showing 1-12 of 37

Last Updated: 09/26/2026